免疫抑制剂治疗炎症性肠病

ndy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R et al. A controlled dlouble blind study of azathioprine in the mamagement of Crohn＇s disease. Gut, 1995;37(5):674-678 　　3 Hawthorne AB, Logan RFA, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. Br& nbsp;Med J , 1992;305(6844):20-22 　　4 Sandborn WJ, Van Os EC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ et al. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn＇s disease. Gastroenterology, 1995;109(6):1808-1817 　　5 Connel WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard Jones et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet, 1994;343(8908):1249-1252 　　6 Feagan BG, McDonald JWD, Rochon J, Laupacis A, Fedorak RN, Kinnear D. Low-dose cyclosporine for the treatment of Crohn＇s disease. N Engl J Med, 1994;330(26):1846-1851 　　7 Jewell DP, Lennard-Jones JE, and the Cyclosporin Study Group of Great Britain and lreland. Oral cyclosporin for chronic active Crohn＇s disease. A multicentre controlled trial. Eur J Gastroenterol Hepatol, 1994;6(3):499-505 　　8 Stange EF, Modigliani R, Penna AS, Wood AJ, Feutren G, Smith PR. European trial of cyclosporin in chronic active Crohn＇s disease: a 12 month study. Gastroenterology, 1995;109(3):774-782 　　9 Brynskov J, Freund L, Rasmussen SN, Lauritsen K.&nbs p;Final report on a placebocontrolled, double-blind, randomized trial of cyclosporin treatment in active chronic Crohn＇s disease. Scand J Gastroenterol, 1991;26(7):689-695 　　10 Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis, 1995;1(1):48-63 　　11 Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula in Crohn＇s disease. Dig Dis Sci, 1994;39(2):374-380 　　12 Hanauer SB, Smith MB. Rapid closur